(Hypertension. 1995;25:377-383.)
© 1995 American Heart Association, Inc.
Articles |
From the Hypertension Research Center, Departments of Internal Medicine and Physiology, University of Medicine and Dentistry of New Jersey, Newark.
Correspondence to Abraham Aviv, MD, Hypertension Research Center, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, 185 S Orange Ave, MSB F-464, Newark, NJ 07103-2714.
| Abstract |
|---|
|
|
|---|
Key Words: calcium pump calcium channels whites hypertension, essential ouabain parathyroid hormone thrombin
| Introduction |
|---|
|
|
|---|
Using platelets as a cellular model, we recently showed that cellular calcium regulation differs in African Americans and whites.4 Moreover, the results suggested that calcium stores in the dense tubules are higher in platelets from African Americans. In our previous work, we used thapsigargin, an inhibitor of the calcium-ATPase in the endo(sarco)plasmic reticulum (SERCA-ATPase), to unravel differences in platelet calcium regulation between African Americans and whites. Inhibition of the SERCA-ATPase results in the gradual depletion of calcium from the endo(sarco)plasmic reticulum (or dense tubules in platelets) and the consequent opening of plasma membrane calcium channels.5 6 7 The rate of calcium entry to the cytosol from the external medium and from intracellular organelles and the rate of calcium extrusion can then be monitored. Under these circumstances, we demonstrated an increased calcium turnover rate (namely, enhanced calcium entry into and extrusion from the cytosol) in platelets from African Americans. The results also suggested that the amount of calcium in the dense tubules was greater in African Americans than in whites. However, these racial differences in platelet calcium homeostasis were demonstrated under specific, nonsteady-state conditions. It is conceivable that such racial differences could arise from mechanisms that do not operate under physiological, steady-state conditions. For instance, it is possible that platelets from African Americans are more sensitive to thapsigargin than platelets from whites. Another possibility is that in response to thapsigargin the relay mechanisms between the dense tubules and the plasma membrane to open the calcium channels operate differently in African Americans than in whites. It was therefore imperative to examine calcium turnover rate and intracellular calcium stores in platelets from African Americans under steady-state conditions and without the inhibition of SERCA-ATPase. This has been the central aim of the present work. Additionally, using fura 2, we examined the effects of ouabain and thrombin on the platelet cytosolic calcium profile. The results strongly support the concept of increased calcium stores in platelets (and presumably other cells) from African Americans compared with those from whites. These racial differences in cellular calcium regulation could play a key role in predisposing African Americans to essential hypertension.
| Methods |
|---|
|
|
|---|
Blood samples were numerically labeled (by F.N.) and immediately transferred to the facilities of the Hypertension Research Center of the University of Medicine and Dentistry of New Jersey where platelet calcium parameters were measured by an investigator (J.H.C.) who did not know the origin of the samples. The remaining samples were stored at -20°C between 3 and 6 months for further measurements (by J.H.C. and Z.F.). The numerical code of the samples was broken only at the completion of the study after platelet calcium parameters for all subjects had been analyzed.
Platelet Preparation
Platelets were isolated at room temperature by differential
centrifugation using a slightly modified procedure that has been
previously described.8 Briefly, platelet-rich plasma was
obtained by centrifugation at 200g for 10 minutes. Plasma
was then centrifuged at 1000g for 10 minutes, and the
platelet pellet was washed three times by centrifugation at
1000g for 10 minutes in buffer consisting of (mmol/L) NaCl
140, KCl 5, glucose 10, HEPES 10, acetylsalicylic acid 0.1, and EGTA
0.2 (pH 7.4, adjusted by NaOH). Bovine serum albumin (0.1%, wt/vol)
was added to the third washing. Platelets were resuspended in HEPES
buffer consisting of (mmol/L) NaCl 140, KCl 5, MgCl2 1,
glucose 10, HEPES 10, and EGTA 0.1 (pH 7.4 at 37°C).
45Ca Uptake and Washout Experiments
Platelets were incubated for 30 minutes at 37°C in HEPES
buffer, except for the omission of EGTA and addition of 1 mmol/L
CaCl2 (pH 7.4), and their number was adjusted to
6x108/mL. Multiple 20-µL aliquots of the platelet
suspension were dispensed into 7.5-mL glass tubes. Then, the uptake
experiments were initiated by the addition of 20 µL of buffer
containing 45Ca (specific activity, 12.7 to 18.7 mCi/mg;
NEZ-013, NEN-DuPont Biotechnology; final activity, 50 to 100 µCi/mL).
Platelet suspensions were incubated at 37°C for up to 240 minutes. To
stop the 45Ca uptake, 5 mL ice-cold HEPES buffer (plus 0.3
mmol/L EGTA) was added to each tube, and the extracellular
radioactivity was removed by rapid filtration through HAWP filters
(pore size, 0.45 µm; Millipore) using two additional 5-mL aliquots of
ice-cold washing buffer. The instantaneous 45Ca uptake
(45Ca added and extracellular radioactivity immediately
removed by filtration) was subtracted from the uptake values.
45Ca washout experiments were initiated after 120 minutes of 45Ca uptake. For this purpose, the 40 µL of 45Ca uptake medium plus platelets was diluted into 5 mL assay buffer (37°C) and the extracellular radioactivity periodically removed by filtration with three additional 5 mL of ice-cold washing buffer. The washout experiments lasted for 120 minutes. Measurements for the uptake and washout experiments were obtained in quadruplicate.
Because of concern regarding platelet stability, 45Ca transport experiments were carried out for a maximum of 4 hours. The capacity of platelets to maintain stable total calcium within 4 hours was previously shown9 ; however, only a small portion of total platelet calcium is exchangeable during this period. Thus, the size of the calcium pools should be considered in relative terms.
Monitoring Cytosolic Free Calcium
Platelets were loaded for 30 minutes at 37°C with 5 µmol/L
fura 2 acetoxymethyl ester (Molecular Probes) in calcium-containing
HEPES buffer. The final centrifugation (to remove the extracellular
dye) can activate some of the platelets and raise the resting cytosolic
free calcium. It was therefore possible that different responses of the
platelets to the final centrifugation could account for racial
differences in the resting cytosolic free calcium. We used three
approaches to ascertain that this is not the case. (1) We measured
cytosolic calcium after removal of the extracellular dye by
centrifugation. This was accomplished by a 7-second spin at maximal
3000g, rapid resuspension of the platelets in 100 µL HEPES
buffer, and the immediate injection of the platelets into cuvettes with
3 mL of the same buffer for fluorescence monitoring. (2) We measured
cytosolic calcium by injecting 100 µL platelets loaded with dye
(without removal of the extra-cellular dye) into 3 mL HEPES buffer plus
0.5 mmol/L MnCl2. This maneuver resulted in an initial
sharp drop followed by a gradual decline in the fluorescence signal.
The instantaneous drop results from the quenching of the extracellular
fura 2 by manganese. The subsequent gradual decline in the signal
reflects manganese influx. The junction between the instantaneous and
gradual declines in the signal represents the resting cytosolic
calcium. (3) We combined the first two methods.
Cytosolic free calcium was also measured after 60 minutes of preincubation with 0.1 mmol/L ouabain before and after treatment with 0.1 NIH U/mL of human thrombin (No. T9135, Sigma Chemical Co). In these experiments, cytosolic calcium levels were monitored for 15 seconds in HEPES buffer with 1 mmol/L calcium or calcium-free HEPES buffer (CaCl2 removed and 0.3 mmol/L EGTA added). Thrombin was then added, and the thrombin-evoked cytosolic calcium transient and posttransient cytosolic calcium were monitored for a total of 300 seconds. The following variables were recorded (Fig 1): cytosolic calcium before treatment with thrombin, the peak thrombin-evoked cytosolic calcium transient, the posttransient cytosolic calcium at 5 minutes of monitoring in calcium-free buffer, and the posttransient cytosolic calcium at 5 minutes of monitoring in calcium-containing buffer after correction with manganese for dye leakage.
|
Cytosolic calcium monitoring was performed with a Fluorolog II spectrofluorometer (model CM-3, SPEX Industries) at excitation wavelengths of 340 and 380 nm and an emission wavelength of 505 nm. The ratio of the maximal and minimal fluorescence was determined by the addition of 50 µmol/L digitonin followed by 15 mmol/L EGTA (pH 8.5). Autofluorescence was determined at the end of each experiment by the addition of 0.5 mmol/L MnCl2 and 50 µmol/L digitonin.
Other Measurements
Intact parathyroid hormone (PTH-1-84) was measured using an
immunoradiometric assay (Nichols Institute Diagnostics). Total
cholesterol, high-density lipoprotein cholesterol, and triglycerides
were measured with a Kodac Ectachem DT 60 analyzer and lipoprotein(a)
with an Apo-Tek Lp(a) ELISA test system (Organon Teknika/Biotechnology
Research Institute). Immunoreactive insulin was measured by a
radioimmunoassay (Coat-A-Count, Diagnostic Products Corp).
Data Analysis
45Ca uptake and washout data were best fitted to
biexponential and monoexponential functions, respectively (Fig 2). Differences in the 45Ca uptake and
washout parameters between platelets from African Americans and whites
were evaluated by the Johnson and Milliken method of modified least
squares to fit parameters of nonlinear models.10 Other
statistical methods included Pearson's correlation analysis,
unpaired Student's t test, and Wilcoxon's rank sum test
[in the case of lipoprotein(a), which demonstrated a non-Gaussian
distribution in whites].
|
Because of technical difficulties, a complete set of cytosolic calcium profiles and 45Ca transport measurements could not be obtained in platelets from all subjects.
| Results |
|---|
|
|
|---|
|
|
45Ca Transport
45Ca uptake was described by two exchangeable calcium
pools (Fig 2, Table 3). The more rapidly exchangeable
pool (au1) was substantially smaller than the slowly
exchangeable pool (au2). Platelets from African Americans
showed a greater accumulation of 45Ca than platelets from
whites. These racial differences related primarily to the greater pool
sizes, which were higher by 42.4% for au1 and 39.8% for
au2 in platelets from African Americans (Table 3).
|
45Ca washout was also described by two calcium pools: a pool that rapidly exchanged 45Ca with the external medium (aw) and a static pool (C) with no apparent 45Ca exchange with the external medium within the monitoring period (Fig 2, Table 3). As 45Ca uptake for 120 minutes was higher in platelets from African Americans, the pool size at the initiation of the 45Ca washout was greater for platelets of African Americans than for those of whites. When 45Ca washout data were normalized and expressed as a percentage of the initial activity (100% at the initiation of the 45Ca washout; Fig 2, Table 3), 45Ca washout was essentially identical in platelets from African Americans versus whites. However, in absolute values, the size of the rapidly exchangeable 45Ca washout pool was greater in platelets from African Americans than in those from whites (246.5±7.5 versus 201.7±7.2 pmol per 1x108 cells, P<.01). This difference reflects the higher levels of 45Ca in platelets of African Americans at the initiation of washout. No racial differences were observed in absolute terms in the size of the apparently static pool of the 45Ca washout (173.5±8.3 and 152.3±7.9 pmol per 1x108 cells for African Americans and whites, respectively).
Cytosolic Free Calcium Monitoring With Fura 2
The low levels of resting platelet cytosolic free calcium recorded
in this work (Table 4) and our previous
work4 5 are in agreement with recent findings by other
researchers.13 14 15 A lower resting free calcium
concentration in African Americans than in whites was observed with the
use of the three approaches described under "Methods," namely,
platelets undergoing final centrifugation to remove the extracellular
dye, platelets without the final centrifugation but subjected to
manganese in the monitoring solution, and platelets subjected to both
the final centrifugation and manganese in the monitoring solution
(Table 4). These results concur with our previous
observations,4 although the absolute values of resting
cytosolic calcium in the present study were slightly higher than
those reported previously.4
|
There were no racial differences in the peak thrombin-evoked cytosolic calcium transient between African Americans and whites (289.3±7.5 versus 277.2±8.0 nmol/L in 1 mmol/L calcium and 185.4±7.2 versus 196.3±5.9 nmol/L in calcium-free buffer). Moreover, no racial differences were observed in the cytosolic calcium levels after 1 hour of treatment with ouabain, before exposure to thrombin (42.9±1.6 versus 42.1±1.7 nmol/L for whites and African Americans, respectively). The peak thrombin-evoked cytosolic calcium response of ouabain-treated platelets was also not different between the two groups (307.0±9.0 versus 296.3±7.7 nmol/L with calcium and 287.5±8.4 versus 283.6±8.6 nmol/L in calcium-free buffer, whites versus African Americans). However, the difference between the posttransient cytosolic calcium at 300 seconds (after correction for dye leak by manganese in 1 mmol/L CaCl2) and the cytosolic calcium levels before the addition of thrombin was significantly higher for ouabain-treated platelets from African Americans than from whites (for calcium-containing buffer, 46.7±4.2 versus 34.5±3.7 nmol/L, P=.033; for calcium-free buffer, 3.0±1.3 versus -1.0±1.4 nmol/L, P=.046).
Correlations Between Platelet Calcium Parameters With Blood
Chemistries
A negative correlation was observed between serum intact
parathyroid hormone and the rate constant (kw) for
45Ca washout (Fig 3). No significant
correlations were noted between platelet calcium parameters and other
blood chemistries, blood pressure parameters, and family history of
essential hypertension and noninsulin-dependent diabetes
mellitus.
|
| Discussion |
|---|
|
|
|---|
The nature of the pools containing more calcium in platelets from African Americans than from whites cannot be readily ascertained from the mathematical analyses of the 45Ca uptake or washout data. It is likely that au1 is associated with the cytosol and intracellular organelles that exchange calcium rapidly with the cytosol. In the nonstimulated state, au2 may be associated with cellular structures such as the dense tubules and secretory granules, which could slowly exchange calcium with the cytosol. However, these are only rough extrapolations from the mathematical models to distinct biological structures. As pointed out previously,9 the distribution of calcium within the cytosol and intracellular organelles such as the dense tubules is unlikely to be homogeneous. Thus, the cellular pools expressed in the 45Ca uptake and washout are likely to reflect the input of groups of pools. This concept is illustrated by the observation that cytosolic free calcium concentrations are slightly lower yet au1 is larger in platelets of African Americans than in those of whites. It is possible that despite lower cytosolic calcium concentrations, the pool size of cytosolic calcium is larger in African Americans. Alternatively, and perhaps more likely, au1 may not entirely represent the cytosol but only a portion of this biological compartment. It is of note, nonetheless, that despite a number of experimental differences between this study and that of Brass,9 the size of the rapidly exchangeable 45Ca pool in both studies is approximately one third that of the slowly exchangeable pool. A major portion of au1 probably overlaps with aw of the washout experiments. Likewise, au2 may in part overlap with C of the washout experiments.
As the capacity to sequester calcium in intracellular organelles is higher in platelets from African Americans than in those from whites, we expected that inhibition of calcium efflux by the sodium-calcium exchange, which is present in human platelets,19 20 would promote a greater accumulation of calcium in platelets from African Americans. We explored this concept by monitoring cytosolic free calcium (using fura 2) after treatment with ouabain. Ouabain inhibits the sodium pump and reduces the transmembrane sodium gradient. This results in the inhibition of the forward mode of the sodium-calcium exchanger, which depends on the transmembrane sodium gradient.
Treatment with ouabain did raise the cytosolic calcium. However, cytosolic free calcium concentrations before treatment with thrombin and the peak thrombin-evoked cytosolic calcium transients were not different in ouabain-treated platelets from African Americans compared with those from whites. Several reasons may account for these unexpected findings. (1) Platelets from African Americans appear to possess not only increased sequestering capacity but also a greater capacity to extrude calcium, thereby masking an influence of increased releasable calcium stores on cytosolic free calcium.4 Although the steady-state efflux experiments in Fig 2 did not reveal any difference in the rate constants of calcium efflux between African Americans and whites, the magnitude of steady-state calcium efflux was greater in the African Americans by virtue of their larger exchangeable calcium pools. Thus, the efflux results are consistent with this possibility. (2) Thrombin stimulation mobilizes only a fraction of stored calcium in both ouabain-treated and ouabain-untreated cells, and this partial mobilization, usually reflected in the peak of the thrombin-evoked calcium transients, could be insufficient to reveal racial differences in the size of calcium stores. (3) An increased sequestering capacity of the dense tubules in African Americans could attenuate the effects of calcium release on cytosolic free calcium concentrations because of increased reuptake of calcium into the dense tubules. (4) The increased intracellular calcium in platelets from African Americans may reside in thrombin-insensitive or nonreleasable compartments. In any event, ouabain-treated platelets from African Americans demonstrated a lag in cytosolic calcium recovery toward resting calcium after the transient phase of calcium release. This might reflect the influence of increased calcium influx, the effects of a greater calcium load on the extrusion process, or a greater dependence of calcium efflux on sodium-calcium exchange in African Americans compared with whites. It is clear that further studies will be required to address this issue.
A number of publications have suggested that circulating parathyroid hormone levels positively correlate with blood pressure and are elevated in some essential hypertensive individuals.21 22 23 As previous reports have also documented elevated parathyroid hormone levels in African Americans,16 24 we explored the relation between platelet calcium regulation and parathyroid hormone. We could identify neither racial differences in intact parathyroid hormone levels nor a positive correlation between intact parathyroid hormone levels and blood pressure. The reasons for the inconsistency among the studies are unclear. In this context, the study16 documenting racial differences in intact parathyroid hormone levels and the present work showed substantial scatter of the data for both African Americans and whites.
Nonetheless, the negative correlation in the present study between intact parathyroid hormone levels and the rate constant of 45Ca washout from the rapidly exchangeable calcium pool suggests that mechanisms engaged in parathyroid hormone regulation and the effect of the hormone on target cells are somehow involved in platelet calcium homeostasis. It is doubtful that a direct interaction between parathyroid hormone and circulating platelets accounts for the findings, as in vitro no effect of human intact parathyroid hormone was demonstrated on platelet 45Ca washout parameters at concentrations (10 and 100 pg/mL) within the range documented in the present work for endogenous levels of the hormone (not shown).
Essential hypertension may be marked by a state of insulin resistance and elevated fasting serum insulin (reviewed in Reference 2525 ). Additionally, platelet function and cytosolic calcium homeostasis could be influenced by circulating lipoproteins.26 27 However, no correlations were observed in the present study between insulin, lipoproteins, and any of the platelet cytosolic calcium parameters.
Based on this study and our previous work,4 we propose the following to explain differences in platelet calcium regulation between African Americans and whites. Larger intracellular pools of exchangeable calcium are present in platelets of African Americans than in those from whites. As the resting cytosolic free calcium concentration under steady state is not higher and is in fact lower in platelets from African Americans, it is logical to conclude that the sequestering mechanisms of calcium into intracellular pools are more active in platelets from African Americans than in those from whites. The augmented capacity to sequester calcium probably involves the dense tubule calcium-ATPase.
Earlier studies demonstrated a positive relation between resting platelet calcium and blood pressure and substantially higher levels of resting platelet calcium in some patients with essential hypertension than in normotensive subjects (eg, see References 2828 and 2929 ). More recent reports documented small differences in resting platelet calcium between normotensive and hypertensive subjects or no correlation between this parameter and the systemic blood pressure (eg, References 3030 and 3131 ). We also failed to show any relation between resting platelet calcium and the systemic blood pressure.32 Our findings therefore do not support the concept that a higher resting platelet calcium level reflects the presence of or the predisposition to essential hypertension. In this regard, the resting calcium levels in vitro may bear little relevance to the cytosolic calcium profiles in vivo, a state in which calcium continuously oscillates.
If the phenomenon of increased exchangeable calcium stores is not limited to platelets but includes cells of the vascular bed, it may result in increased sensitivity to vasoactive agents that raise the cytosolic calcium, including a number of hormones and autacoids and particularly endogenous ouabain33 or other ouabainlike factors that inhibit the sodium pump. Moreover, increased intracellular calcium stores in African Americans could explain the greater effectiveness of calcium antagonists than ß-adrenergic blockers or angiotensin-converting enzyme inhibitors in the treatment of essential hypertension in this racial group.34 35 36
| Acknowledgments |
|---|
Received April 29, 1994; first decision July 19, 1994; accepted October 2, 1994.
| References |
|---|
|
|
|---|
2. National Center for Health Statistics. Health, United States 1988. Washington, DC: US Public Health Service; 1989:iii-208. US Dept of Health and Human Services publication (PHS) 89-1232.
3.
Hypertension prevalence and the status of awareness,
treatment and control in the United States.
Hypertension. 1985;7:457-468.
4. Kimura M, Cho J-H, Lasker N, Aviv A. Differences in platelet calcium regulation between African Americans and Caucasians. JHypertens. 1994;12:199-207. [Medline] [Order article via Infotrieve]
5.
Kimura M, Lasker N, Aviv A. Thapsigargin-evoked changes in
human platelet Ca2+, Na+,
pH and membrane potential. J Physiol (Lond). 1993;464:1-13.
6.
Vostal JG, Jackson WL, Shulman NR. Cytosolic and stored
calcium antagonistically control tyrosine phosphorylation of specific
platelet proteins. J Biol Chem. 1991;266:16911-16916.
7.
Lytton J, Westlin M, Hanley MR. Thapsigargin inhibits the
sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium
pumps. J Biol Chem. 1991;266:17067-17071.
8. Kimura M, Lasker N, Aviv A. Cyclic nucleotides attenuate thrombin-evoked alterations in parameters of platelet Na/H antiport: the role of cytosolic Ca. J Clin Invest. 1992;89:1121-1127.
9.
Brass LF. Ca2+ homeostasis in unstimulated
platelets. J Biol Chem. 1984;259:12563-12570.
10. Johnson P, Milliken PA. A single procedure for testing linear hypotheses about the parameters of non-linear models using weighted test squares. Communications in Statistics Stimulation and Computation. 1983;12:135-145.
11.
Guyton JR, Dahlen GH, Patsch W, Kautz JA, Gotto AM Jr.
Relationship of plasma lipoprotein Lp(a) levels to race and
apolipoprotein B. Arteriosclerosis. 1985;5:265-272.
12.
Srinivasan SR, Dahlen GH, Jarpa RA, Webber LS, Berenson GS.
Racial (black-white) differences in serum lipoprotein (a) distribution
and its relation to parental myocardial infarction in children:
Bogolusa Heart Study. Circulation. 1991;84:160-167.
13.
Jacobs DB, Sowers JR, Hmeidan A, Niyogi T, Simpson L, Standley
PR. Effects of weight reduction on cellular cation metabolism and
vascular resistance. Hypertension. 1993;21:308-314.
14. Standley PR, Ali S, Bapna C, Sowers JR. Increased platelet cytosolic calcium responses to low density lipoprotein in type II diabetes with and without hypertension. Am J Hypertens. 1993;6:938-943. [Medline] [Order article via Infotrieve]
15. Ishida T, Matuura H, Ishida-Kainouchi M, Ozono R, Watanabe M, Kajiyama G, Oshima T. Na+-Ca2+ exchange modulates Ca2+ handling of human platelets by altering intracellular Ca2+ store size. J Hypertens. 1993;11:1089-1095. [Medline] [Order article via Infotrieve]
16. Brickman AS, Nyby MD, Griffiths RF, von Hungen K, Tuck ML. Racial differences in platelet cytosolic calcium and calcitrophic hormones in normotensive subjects. Am J Hypertens. 1993;6:46-51. [Medline] [Order article via Infotrieve]
17. Miller MA, Sagrella GA, Markandu ND, MacGregor GA. Determinants of platelet intracellular free calcium in essential hypertension and effect of stimulation by arginine vasopressin. Am J Hypertens. 1993;6:209-216. [Medline] [Order article via Infotrieve]
18. Nakamura A, Gardner J, Hatori N, Nakamura M, Fine BP, Aviv A. Differences of Ca2+ regulation in skin fibroblasts from blacks and caucasians. J Cell Physiol. 1989;138:367-374. [Medline] [Order article via Infotrieve]
19.
Kimura M, Aviv A, Reeves JP. K+-dependent
Na+/Ca2+ exchange in human
platelets. J Biol Chem. 1993;268:6874-6877.
20. Kimura M, Aviv A. Regulation of the cytosolic pH setpoint for activation of the Na+/H+ antiport in human platelets: the role of the Na+/Ca2+ exchange, the Na+-K+-Cl- cotransport and cellular volume. Pflugers Arch. 1993;422:585-590. [Medline] [Order article via Infotrieve]
21.
Brickman A, Nyby M, von Hungen K, Eggena P, Tuck M.
Parathyroid hormone, platelet calcium, and blood pressure in
normotensive subjects. Hypertension. 1991;18:176-182.
22. Grobbee DE, Hackeng WHL, Birkenhager JC, Hofman A. Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressure. Br Med J. 1988;296:814-816.
23. Resnick LM, Muller FB, Laragh JH. Calcium regulating hormones in essential hypertension. Ann Intern Med. 1986;105:649-654.
24. Bell NH, Greene A, Epskin S, Oexmann MJ, Shaw S, Shary J. Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest. 1985;76:470-473.
25. Aviv A. The roles of Ca2+, protein kinase C and the Na+/H+ antiport in the development of hypertension and insulin resistance. J Am Soc Nephrol. 1992;32:1049-1063.
26. Aviram M, Brock JG. Platelet activation by plasma lipoproteins. Prog Cardiovasc Dis. 1987;30:61-72. [Medline] [Order article via Infotrieve]
27.
Block LH, Knorr M, Vogt E, Locher R, Vetter W, Groscurth P,
Qiao B-Y, Pometta D, James R, Regenass M, Pletcher A. Low density
lipoprotein causes general cellular activation with increased
phosphatidylinositol turnover and lipoprotein catabolism. Proc
Natl Acad Sci U S A. 1988;85:885-889.
28. Erne P, Bolli P, Burgisser E, Buhler FR. Correlation of platelet calcium with blood pressure: effect of antihypertensive therapy. N Engl J Med. 1984;310:1084-1088. [Abstract]
29.
Lechi A, Lechi C, Bonadonna G, Singaglia D, Carradini P,
Polignano R, Arosio E, Covi G, de Togni P. Increased basal and
thrombin-induced free calcium in platelets of essential hypertensive
patients. Hypertension. 1987;9:230-235.
30. Duggan J, Kilfeather S, Sheridan T, O'Brien E, O'Malley K. The effects of age on platelet intracellular free calcium concentration in normotensives and hypertensives. J Hypertens. 1991;9:845-850. [Medline] [Order article via Infotrieve]
31. Miller MA, Sangella GA, Markandu ND, MacGregor GA. Determinants of platelet intracellular free calcium in essential hypertension and effect of stimulation by arginine vasopressins. Am J Hypertens. 1993;6:209-216.
32. Gardner JP, Cho J-H, Skurnick JH, Awad G, Gutkin M, Byrd LH, Lasker N, Aviv A. Blood pressure inversely correlates with thrombin-evoked calcium rise in platelets. Hypertension. 1994;23(part 1):703-709.
33.
Blaustein MP. Physiological effects of endogenous ouabain:
control of intracellular Ca2+ stores and cell
responsiveness. Am J Physiol. 1993;264:C1367-C1387.
34. Murphy MB. Selecting optimum antihypertensive therapy: indications for choosing a calcium channel blocker. Am J Med. 1992;93(suppl 2A):38s-44s.
35. Zing W, Ferguson RK, Vlasses PH. Calcium antagonists in elderly and black hypertensive patients. Arch Intern Med. 1991;151: 2154-2162.
36. Saunders E, Weir MR, Kong BW, Hollifield J, Gray J, Vertes V, Sowers JR, Zemel MB, Curry C, Schoenberger J, Wright JT, Kirkendall W, Conradi EC, Jenkins P, McLean B, Massie B, Berenson G, Flamenbaum W. A comparison of the efficacy and safety of a ß-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med. 1990;150: 1707-1713.
This article has been cited by other articles:
![]() |
J. M Khan and D G. Beevers Management of hypertension in ethnic minorities Heart, August 1, 2005; 91(8): 1105 - 1109. [Full Text] [PDF] |
||||
![]() |
S. S. Franklin, J. R. Pio, N. D. Wong, M. G. Larson, E. P. Leip, R. S. Vasan, and D. Levy Predictors of New-Onset Diastolic and Systolic Hypertension: The Framingham Heart Study Circulation, March 8, 2005; 111(9): 1121 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Wright Jr, M. Rahman, A. Scarpa, M. Fatholahi, V. Griffin, R. Jean-Baptiste, M. Islam, M. Eissa, S. White, and J. G. Douglas Determinants of Salt Sensitivity in Black and White Normotensive and Hypertensive Women Hypertension, December 1, 2003; 42(6): 1087 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, T. Adachi, V. M. Bolotina, C. Knowles, K. A. Ault, and R. A. Cohen Abnormal Platelet Function and Calcium Handling in Dahl Salt-Hypertensive Rats Hypertension, April 1, 2001; 37(4): 1129 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Horiguchi, M. Kimura, J. Skurnick, and A. Aviv Parameters of Lymphocyte Na+-Ca2+ Regulation and Blood Pressure : The Gender Effect Hypertension, November 1, 1998; 32(5): 869 - 874. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |